Bill: 119-HR10857
2026012515
NO TEXT USED
To amend the Federal Food, Drug, and Cosmetic Act and Public Health Service Act to advance the next-generation of clinical development of novel treatments and cures, and for other purposes.
Current status: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
SenateUser voting will unlock when the full text is made available. Thank you for your patience.
Summary Provided by Congressional Research Service
No summary is currently available for this legislature.
Detailed text is not currently available. Please check back later.